Faithward Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
5,362
+507
| +10% | +$23.5K | 0.04% | 239 |
|
|
2025
Q1 | $296K | Buy |
4,855
+349
| +8% | +$21.3K | 0.05% | 211 |
|
|
2024
Q4 | $255K | Sell |
4,506
-303
| -6% | -$17.1K | 0.04% | 216 |
|
|
2024
Q3 | $249K | Buy |
+4,809
| New | +$249K | 0.04% | 238 |
|
|
2024
Q2 | – | Sell |
-4,894
| Closed | -$265K | – | 254 |
|
|
2024
Q1 | $265K | Buy |
+4,894
| New | +$265K | 0.05% | 214 |
|
|
2023
Q2 | – | Sell |
-4,373
| Closed | -$302K | – | 274 |
|
|
2023
Q1 | $302K | Buy |
+4,373
| New | +$302K | 0.07% | 146 |
|
|
2020
Q2 | – | Sell |
-4,348
| Closed | -$242K | – | 215 |
|
|
2020
Q1 | $242K | Sell |
4,348
-40
| -0.9% | -$2.23K | 0.07% | 140 |
|
|
2019
Q4 | $282K | Buy |
+4,388
| New | +$282K | 0.07% | 137 |
|